Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Christophe

Showing results (331-340 of 369) with videos related to

Pageof 37
Sort By:
FEBS Letters|January 30, 1984
Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic aciniJ P Dehaye, J Winand, P Michel, et al.
Biochimica Et Biophysica Acta|July 22, 1991
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranesP Gourlet, P De Neef, M C Woussen-Colle, et al.
European Journal of Biochemistry|July 1, 1992
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonistP Robberecht, P Gourlet, P De Neef, et al.
FEBS Letters|July 9, 1984
Phospholipase A2 activity of pancreatic secretory factor, a new secretagogue isolated from the venom of Heloderma suspectumJ P Dehaye, J Winand, P Michel, et al.
Molecular Pharmacology|August 1, 1992
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21P Robberecht, P Gourlet, P De Neef, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1985
Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardiumC Devos, P Robberecht, P Nokin, et al.
Pflugers Archiv : European Journal of Physiology|April 1, 1983
Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal speciesP Chatelain, P Robberecht, M Waelbroeck, et al.
British Journal of Pharmacology|September 1, 1989
Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypesM Waelbroeck, M Tastenoy, J Camus, et al.
European Journal of Pharmacology|September 1, 1992
Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptorsM Waelbroeck, J Camus, M Tastenoy, et al.
Peptides|January 1, 1986
Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptorsP Robberecht, N Yanaihara, C Yanaihara, et al.
Pageof 37

Showing results (331-340 of 369) with videos related to

Sort By:
Pageof 37
FEBS Letters|January 30, 1984
Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic aciniJ P Dehaye, J Winand, P Michel, et al.
Biochimica Et Biophysica Acta|July 22, 1991
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranesP Gourlet, P De Neef, M C Woussen-Colle, et al.
European Journal of Biochemistry|July 1, 1992
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonistP Robberecht, P Gourlet, P De Neef, et al.
FEBS Letters|July 9, 1984
Phospholipase A2 activity of pancreatic secretory factor, a new secretagogue isolated from the venom of Heloderma suspectumJ P Dehaye, J Winand, P Michel, et al.
Molecular Pharmacology|August 1, 1992
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21P Robberecht, P Gourlet, P De Neef, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1985
Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardiumC Devos, P Robberecht, P Nokin, et al.
Pflugers Archiv : European Journal of Physiology|April 1, 1983
Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal speciesP Chatelain, P Robberecht, M Waelbroeck, et al.
British Journal of Pharmacology|September 1, 1989
Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypesM Waelbroeck, M Tastenoy, J Camus, et al.
European Journal of Pharmacology|September 1, 1992
Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptorsM Waelbroeck, J Camus, M Tastenoy, et al.
Peptides|January 1, 1986
Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptorsP Robberecht, N Yanaihara, C Yanaihara, et al.
Pageof 37